Advertisement
ATEC vs IRTC
Which Stock Would AI Choose? Alphatec Holdings (ATEC) vs. iRhythm Holdings (IRTC) Stock Comparison
Key Takeaways
- Both ATEC and IRTC operate in the medical devices sector, focusing on spine surgery and cardiac monitoring, respectively, with recent quarterly revenue growth but ongoing losses.
- ATEC reported Q1 2026 revenue of $192 million (up 14% YoY) amid a sharp stock decline to a 52-week low near $7, reflecting earnings miss and high volatility (YTD -54%).
- IRTC posted Q1 2026 revenue of $199 million (up 26% YoY), trading around $117 with relative stability despite YTD losses of about 33% from prior highs.
- IRTC shows stronger revenue scale ($788M TTM vs. $764M for ATEC) and less extreme recent price swings.
- Market caps differ notably: IRTC at ~$3.9B vs. ATEC at ~$1.1B, highlighting scale advantages for IRTC.
- Analyst targets suggest upside potential for both, but IRTC's consistency positions it better in current market conditions.
Introduction
This stock comparison examines ATEC (Alphatec Holdings, Inc.) and IRTC (iRhythm Holdings, Inc.), two medical device firms navigating growth in specialized healthcare markets. Alphatec focuses on spinal implant technologies, while iRhythm specializes in ambulatory cardiac monitoring via wearable patches. Traders seeking exposure to medtech innovation and investors tracking relative performance in a volatile sector will find value here. Recent earnings highlight revenue momentum amid profitability challenges, offering insights into stock comparison, market positioning, and potential shifts in sentiment.
ATEC Overview and Recent Performance
Alphatec Holdings, Inc. (ATEC) develops implants, instruments, and imaging systems for spinal disorder treatments. In recent market activity, the stock has faced significant pressure, hitting a 52-week low near $6.85 after Q1 2026 earnings on May 5 showed revenue of $192.1 million (up 14% YoY, missing estimates slightly) and break-even adjusted EPS, though GAAP EPS missed at -$0.22. Surgical revenue grew 17%, driven by 21% case volume increase and 23% net new surgeon users. A debt refinancing with JPMorgan reduced annual interest by over $6 million, extending maturities to 2031. Sentiment has soured due to the earnings reaction, with shares down over 30% in a single session amid high volume, contrasting YTD gains earlier in the year now erased. Volatility persists in this competitive spine market.
IRTC Overview and Recent Performance
iRhythm Holdings, Inc. (IRTC) provides wearable biosensors for cardiac arrhythmia detection, emphasizing long-term ECG monitoring. Recent weeks have seen steadier price action around $117, down modestly from peaks but supported by Q1 2026 results: revenue of $199.4 million (up 25.7% YoY, beating estimates). The company continues expanding its Zio platform, with data presentations at conferences like HRS 2026 underscoring advantages over short-term Holter monitors. Trading near the lower end of its 52-week range ($112-$212), shares reflect YTD declines of about 33% but show resilience post-earnings compared to peers. Growth drivers include market expansion and AI enhancements, fostering positive analyst views despite ongoing losses (TTM EPS -$0.85). Sector tailwinds in remote monitoring bolster sentiment.
Trending AI Robots
Tickeron’s Trending AI Robots page curates the top 25 AI trading bots from over 351 available, each scanning thousands of tickers across stocks, ETFs, and crypto for optimal signals in current conditions. These bots employ diverse strategies like trend-following, volatility plays, and sector-specific trades (e.g., semiconductors, energy), with timeframes from 5 minutes to 60 minutes. Impressive stats include annualized returns up to +169%, win rates of 51-88%, and profit factors to 11.70, often with tight risk controls like 3% take-profit/2% stop-loss corridors. Bots trade 1-18 tickers per portfolio, delivering hands-free automation. Explore these high-performers to enhance your trading edge.
Head-to-Head Comparison
ATEC and IRTC share medtech roots but diverge in focus: spine hardware vs. cardiac wearables. Growth drivers contrast—ATEC leverages surgeon adoption and biologics, while IRTC benefits from telehealth trends and AI diagnostics. Recent momentum favors IRTC, with steadier trading and stronger Q1 beat vs. ATEC's post-earnings plunge. Risk factors include ATEC's higher beta (0.97) and debt history, though refinanced, against IRTC's 1.33 beta and scale ($3.9B market cap vs. $1.1B). Both unprofitable (negative EPS), IRTC edges in TTM revenue and stability, while ATEC offers niche upside if execution improves. Market sentiment tilts toward IRTC's consistency.
Tickeron AI Verdict
Tickeron’s AI currently favors IRTC over ATEC, based on superior recent revenue growth, earnings beats, lower relative volatility, and stronger trend consistency in recent market activity. While ATEC shows procedural momentum and debt relief, its sharp price reaction highlights risks. IRTC's positioning in expanding cardiac monitoring suggests higher probability of near-term outperformance, though both carry growth-oriented profiles.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATEC is a Buy and IRTC is a Buy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ATEC’s FA Score shows that 0 FA rating(s) are green whileIRTC’s FA Score has 0 green FA rating(s).
- ATEC’s FA Score: 0 green, 5 red.
- IRTC’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ATEC’s TA Score shows that 5 TA indicator(s) are bullish while IRTC’s TA Score has 6 bullish TA indicator(s).
- ATEC’s TA Score: 5 bullish, 4 bearish.
- IRTC’s TA Score: 6 bullish, 4 bearish.
Price Growth
ATEC (@Medical/Nursing Services) experienced а +1.02% price change this week, while IRTC (@Medical/Nursing Services) price change was +9.04% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +2.55%. For the same industry, the average monthly price growth was -0.43%, and the average quarterly price growth was -11.48%.
Reported Earning Dates
ATEC is expected to report earnings on Jul 30, 2026.
IRTC is expected to report earnings on Jul 30, 2026.
Industries' Descriptions
@Medical/Nursing Services (+2.55% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
| ATEC | IRTC | ATEC / IRTC | |
| Capitalization | 1.37B | 4.16B | 33% |
| EBITDA | 6.36M | 12.6M | 50% |
| Gain YTD | -57.605 | -28.720 | 201% |
| P/E Ratio | N/A | N/A | - |
| Revenue | 787M | 788M | 100% |
| Total Cash | 140M | 550M | 25% |
| Total Debt | 603M | 729M | 83% |
ATEC | IRTC | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 35 | 20 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 99 Overvalued | 47 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 66 | |
SMR RATING 1..100 | 100 | 97 | |
PRICE GROWTH RATING 1..100 | 60 | 58 | |
P/E GROWTH RATING 1..100 | 99 | 100 | |
SEASONALITY SCORE 1..100 | 50 | 16 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
IRTC's Valuation (47) in the Medical Specialties industry is somewhat better than the same rating for ATEC (99). This means that IRTC’s stock grew somewhat faster than ATEC’s over the last 12 months.
IRTC's Profit vs Risk Rating (66) in the Medical Specialties industry is somewhat better than the same rating for ATEC (100). This means that IRTC’s stock grew somewhat faster than ATEC’s over the last 12 months.
IRTC's SMR Rating (97) in the Medical Specialties industry is in the same range as ATEC (100). This means that IRTC’s stock grew similarly to ATEC’s over the last 12 months.
IRTC's Price Growth Rating (58) in the Medical Specialties industry is in the same range as ATEC (60). This means that IRTC’s stock grew similarly to ATEC’s over the last 12 months.
ATEC's P/E Growth Rating (99) in the Medical Specialties industry is in the same range as IRTC (100). This means that ATEC’s stock grew similarly to IRTC’s over the last 12 months.
| ATEC | IRTC | |
|---|---|---|
| RSI ODDS (%) | 5 days ago 74% | 5 days ago 85% |
| Stochastic ODDS (%) | 5 days ago 80% | 5 days ago 73% |
| Momentum ODDS (%) | 5 days ago 80% | 5 days ago 81% |
| MACD ODDS (%) | N/A | 5 days ago 79% |
| TrendWeek ODDS (%) | 5 days ago 79% | 5 days ago 80% |
| TrendMonth ODDS (%) | 5 days ago 80% | 5 days ago 81% |
| Advances ODDS (%) | 5 days ago 82% | 5 days ago 80% |
| Declines ODDS (%) | 14 days ago 83% | 20 days ago 81% |
| BollingerBands ODDS (%) | 5 days ago 89% | 5 days ago 78% |
| Aroon ODDS (%) | 5 days ago 75% | 5 days ago 78% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| IQI | 10.20 | 0.03 | +0.29% |
| INVESCO QUALITY Municipal SECURITIES | |||
| GBIL | 99.91 | 0.05 | +0.05% |
| Goldman Sachs Access Treasury 0-1 Yr ETF | |||
| UPGR | 26.81 | N/A | N/A |
| Xtrackers US Green Infras Sel Eq ETF | |||
| NOWL | 4.31 | N/A | N/A |
| GraniteShares 2x Long NOW Daily ETF | |||
| VAMO | 35.65 | -0.16 | -0.45% |
| Cambria Value and Momentum ETF | |||
ATEC and
Correlation & Price change
A.I.dvisor indicates that over the last year, ATEC has been loosely correlated with SIBN. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ATEC jumps, then SIBN could also see price increases.
| Ticker / NAME | Correlation To ATEC | 1D Price Change % | ||
|---|---|---|---|---|
| ATEC | 100% | +0.68% | ||
| SIBN - ATEC | 45% Loosely correlated | +1.85% | ||
| TMDX - ATEC | 44% Loosely correlated | +1.49% | ||
| IRTC - ATEC | 42% Loosely correlated | +1.57% | ||
| PODD - ATEC | 40% Loosely correlated | +2.94% | ||
| IRMD - ATEC | 37% Loosely correlated | +2.99% | ||
More | ||||
IRTC and
Correlation & Price change
A.I.dvisor indicates that over the last year, IRTC has been loosely correlated with ATEC. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if IRTC jumps, then ATEC could also see price increases.
| Ticker / NAME | Correlation To IRTC | 1D Price Change % | ||
|---|---|---|---|---|
| IRTC | 100% | +1.57% | ||
| ATEC - IRTC | 42% Loosely correlated | +0.68% | ||
| CNMD - IRTC | 40% Loosely correlated | +3.27% | ||
| STE - IRTC | 38% Loosely correlated | +2.78% | ||
| PODD - IRTC | 37% Loosely correlated | +2.94% | ||
| BIO - IRTC | 37% Loosely correlated | -0.08% | ||
More | ||||